Frances M. Martin

614 total citations
13 papers, 460 citations indexed

About

Frances M. Martin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Frances M. Martin has authored 13 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Frances M. Martin's work include Prostate Cancer Diagnosis and Treatment (8 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Prostate Cancer Treatment and Research (5 papers). Frances M. Martin is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Prostate Cancer Treatment and Research (5 papers). Frances M. Martin collaborates with scholars based in United States, Canada and South Africa. Frances M. Martin's co-authors include Ashish M. Kamat, Aditi Das, Arlene O. Siefker‐Radtke, Robert S. Svatek, Lauren Marquis, Woonyoung Choi, Colin P. Dinney, Jay B. Shah, Michael B. Williams and David J. McConkey and has published in prestigious journals such as JAMA, Cancer and The Journal of Urology.

In The Last Decade

Frances M. Martin

12 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frances M. Martin United States 8 215 162 158 136 99 13 460
Simona Cagiano Italy 9 215 1.0× 123 0.8× 120 0.8× 98 0.7× 140 1.4× 11 485
Bruce S. Fischer United States 11 224 1.0× 290 1.8× 103 0.7× 235 1.7× 44 0.4× 22 574
J. Schwarz Germany 7 165 0.8× 61 0.4× 69 0.4× 60 0.4× 71 0.7× 9 308
Jian Gu China 10 167 0.8× 71 0.4× 54 0.3× 78 0.6× 61 0.6× 20 310
Chih Yi Chen Taiwan 8 328 1.5× 205 1.3× 51 0.3× 48 0.4× 138 1.4× 14 491
Caipeng Qin China 12 202 0.9× 85 0.5× 93 0.6× 49 0.4× 95 1.0× 41 359
Dimitris Delakas Greece 9 269 1.3× 48 0.3× 90 0.6× 87 0.6× 197 2.0× 9 391
Lujia Zou China 10 182 0.8× 43 0.3× 92 0.6× 108 0.8× 127 1.3× 26 353
Ben George United States 6 220 1.0× 117 0.7× 131 0.8× 294 2.2× 89 0.9× 13 473

Countries citing papers authored by Frances M. Martin

Since Specialization
Citations

This map shows the geographic impact of Frances M. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances M. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances M. Martin more than expected).

Fields of papers citing papers by Frances M. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances M. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances M. Martin. The network helps show where Frances M. Martin may publish in the future.

Co-authorship network of co-authors of Frances M. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Frances M. Martin. A scholar is included among the top collaborators of Frances M. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances M. Martin. Frances M. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Teplitsky, Seth, Joon Kyung Kim, Derek B. Allison, et al.. (2025). Prognostic significance of pathologic response to neoadjuvant chemotherapy in muscle-invasive urothelial carcinoma of the bladder with histologic subtype. Urologic Oncology Seminars and Original Investigations. 43(9). 521.e19–521.e27.
2.
Newcomb, Lisa F., Jeannette M. Schenk, Yingye Zheng, et al.. (2024). Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. JAMA. 331(24). 2084–2084. 22 indexed citations
3.
Schenk, Jeannette M., Menghan Liu, Marian L. Neuhouser, et al.. (2022). Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study. Nutrition and Cancer. 75(2). 618–626. 9 indexed citations
4.
Filson, Christopher P., Kehao Zhu, Yijian Huang, et al.. (2022). Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance. The Journal of Urology. 208(5). 1037–1045. 4 indexed citations
5.
Zhu, Kehao, Yingye Zheng, Lisa F. Newcomb, et al.. (2021). Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. Cancer. 128(2). 269–274. 5 indexed citations
6.
Chang, Peter, Lisa F. Newcomb, Anna Faino, et al.. (2021). Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort. Urology Practice. 8(5). 576–582. 2 indexed citations
7.
Cooperberg, Matthew R., Yingye Zheng, Anna Faino, et al.. (2020). Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability. JAMA Oncology. 6(10). e203187–e203187. 39 indexed citations
8.
Zhu, Kehao, Yingye Zheng, Lisa F. Newcomb, et al.. (2020). PD62-09 EVALUATING THE OUTCOMES OF ACTIVE SURVEILLANCE IN GLEASON GRADE GROUP 2 PROSTATE CANCER: PROSPECTIVE RESULTS FROM THE CANARY-PASS COHORT. The Journal of Urology. 203(Supplement 4). 1 indexed citations
9.
Liss, Michael A., Lisa F. Newcomb, Yingye Zheng, et al.. (2020). Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study. The Journal of Urology. 204(4). 701–706. 22 indexed citations
10.
McConkey, David J., Woonyoung Choi, Lauren Marquis, et al.. (2009). Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer and Metastasis Reviews. 28(3-4). 335–344. 311 indexed citations
11.
Martin, Frances M. & Ashish M. Kamat. (2009). Definition and management of patients with bladder cancer who fail BCG therapy. Expert Review of Anticancer Therapy. 9(6). 815–820. 25 indexed citations
12.
Martin, Frances M., Andrew Harris, Randall G. Rowland, et al.. (2008). Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists.. PubMed. 12(2). 253–258. 11 indexed citations
13.
Martin, Frances M. & Randall G. Rowland. (2007). Urologic Malignancies in Pregnancy. Urologic Clinics of North America. 34(1). 53–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Cagiano Breakdown of academic impact, for papers by Bruce S. Fischer Breakdown of academic impact, for papers by J. Schwarz Breakdown of academic impact, for papers by Jian Gu Breakdown of academic impact, for papers by Chih Yi Chen Breakdown of academic impact, for papers by Caipeng Qin Breakdown of academic impact, for papers by Dimitris Delakas Breakdown of academic impact, for papers by Lujia Zou Breakdown of academic impact, for papers by Ben George
Rankless by CCL
2026